pharming


Also found in: Dictionary, Thesaurus, Financial, Encyclopedia, Wikipedia.

pharming

(fär′mĭng)
n.
The production of pharmaceuticals from genetically altered plants or animals.

pharm v.
Biotechnology (1) The production of useful molecules—e.g., proteins and pharmaceuticals from genetically engineered animals or plants
(2) The process of genetically engineering crops to protect them or consumers from disease
Informatics A portmanteau of phishing and farming. Phishing is a type of computer attack to obtain access credentials such as user names and passwords
Substance abuse A putative type of recreational drug use by teenagers in the US suburbs in which they borrow multiple prescription drugs from their home medicine cabinets, take them to parties and pool the pills in bowls for free consumption, based on the assumption that if enough of them have ‘borrowed’ enough of the right prescription drugs from the family medicine cabinets, some sort of desirable neuropharmacologic effect will ensue

pharming

use of genetically manipulated farm animals, for example sheep and goats, and crop plants in order to produce large quantities of expensive human proteins of pharmaceutical value.
References in periodicals archive ?
Pharming Shield monitors customers' web site pages, SSL certificates and DNS servers for unauthorized changes every 2 minutes.
Pharming has acquired 57 issued patents, including 19 in the US as well as several pending patent applications of PPL Therapeutics.
Under an agreement, RUCONEST is manufactured by Pharming Group NV in the Netherlands.
15 April 2010 - Biotech company Swedish Orphan Biovitrum (STO: BVT) will distribute the drug Rhucin for treatment of hereditary angioedema (HAE) attacks, developed by Dutch Pharming Group NV (AMS: PHARM), in 24 European Union (EU) countries, Norway, Iceland and Switzerland.
"Pharming is 'phishing' without the lure," says Scott Chasin, chief technology officer with MX Logic.
The termination follows Infigen's earlier announcement that a Wisconsin court had granted the company a restraining order against Netherlands-based Pharming Holding N.V., and its subsidiaries.
Following completion of the financing, Pharming Group NV expects EUR15.0m in net proceeds after subtraction of transaction fees and costs.
Biopharmaceutical company Santarus Inc (NasdaqGS:SNTS) and Pharming Group NV (NYSE Euronext: PHARM) jointly announced on Wednesday the submission of a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) to obtain marketing approval for RUCONEST 50 U/kg.
As a spin-off of Pharming's development of products for systemic infections, certain small peptides were developed and patent applications were filed, a project in collaboration with the Department of Infectious Diseases of the Leiden University Medical Center.
Biotech company Pharming Group NV (Euronext: PHARM) today announced the receipt of a USD10m milestone payment.